Annual D&A
$227.00 K
+$105.00 K+86.07%
December 31, 2023
Summary
- As of February 8, 2025, RGLS annual depreciation & amortization is $227.00 thousand, with the most recent change of +$105.00 thousand (+86.07%) on December 31, 2023.
- During the last 3 years, RGLS annual D&A has fallen by -$240.00 thousand (-51.39%).
- RGLS annual D&A is now -91.01% below its all-time high of $2.52 million, reached on December 31, 2017.
Performance
RGLS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$90.00 K
+$1000.00+1.12%
September 30, 2024
Summary
- As of February 8, 2025, RGLS quarterly depreciation & amortization is $90.00 thousand, with the most recent change of +$1000.00 (+1.12%) on September 30, 2024.
- Over the past year, RGLS quarterly D&A has increased by +$1000.00 (+1.12%).
- RGLS quarterly D&A is now -87.12% below its all-time high of $699.00 thousand, reached on March 31, 2017.
Performance
RGLS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$336.00 K
+$34.00 K+11.26%
September 30, 2024
Summary
- As of February 8, 2025, RGLS TTM depreciation & amortization is $336.00 thousand, with the most recent change of +$34.00 thousand (+11.26%) on September 30, 2024.
- Over the past year, RGLS TTM D&A has increased by +$34.00 thousand (+11.26%).
- RGLS TTM D&A is now -87.58% below its all-time high of $2.71 million, reached on June 30, 2017.
Performance
RGLS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
RGLS Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +86.1% | +1.1% | +11.3% |
| 3 y3 years | -51.4% | +190.3% | +147.1% |
| 5 y5 years | -90.0% | -29.1% | -50.3% |
RGLS Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.5% | +86.1% | at high | +246.2% | -26.8% | +175.4% |
| 5 y | 5-year | -75.6% | +86.1% | -73.1% | +246.2% | -63.9% | +175.4% |
| alltime | all time | -91.0% | +86.1% | -87.1% | +246.2% | -87.6% | +175.4% |
Regulus Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $90.00 K(+1.1%) | $336.00 K(+11.3%) |
| Jun 2024 | - | $89.00 K(+9.9%) | $302.00 K(+16.2%) |
| Mar 2024 | - | $81.00 K(+6.6%) | $260.00 K(+14.5%) |
| Dec 2023 | $227.00 K(+86.1%) | $76.00 K(+35.7%) | $227.00 K(+23.4%) |
| Sep 2023 | - | $56.00 K(+19.1%) | $184.00 K(+15.0%) |
| Jun 2023 | - | $47.00 K(-2.1%) | $160.00 K(+11.1%) |
| Mar 2023 | - | $48.00 K(+45.5%) | $144.00 K(+18.0%) |
| Dec 2022 | $122.00 K(-73.4%) | $33.00 K(+3.1%) | $122.00 K(-6.2%) |
| Sep 2022 | - | $32.00 K(+3.2%) | $130.00 K(-4.4%) |
| Jun 2022 | - | $31.00 K(+19.2%) | $136.00 K(-9.3%) |
| Mar 2022 | - | $26.00 K(-36.6%) | $150.00 K(-67.3%) |
| Dec 2021 | $459.00 K(-1.7%) | $41.00 K(+7.9%) | $459.00 K(-12.2%) |
| Sep 2021 | - | $38.00 K(-15.6%) | $523.00 K(-12.7%) |
| Jun 2021 | - | $45.00 K(-86.6%) | $599.00 K(-11.4%) |
| Mar 2021 | - | $335.00 K(+219.0%) | $676.00 K(+44.8%) |
| Dec 2020 | $467.00 K(-49.8%) | $105.00 K(-7.9%) | $467.00 K(-5.3%) |
| Sep 2020 | - | $114.00 K(-6.6%) | $493.00 K(-2.6%) |
| Jun 2020 | - | $122.00 K(-3.2%) | $506.00 K(-8.8%) |
| Mar 2020 | - | $126.00 K(-3.8%) | $555.00 K(-40.4%) |
| Dec 2019 | $931.00 K(-58.8%) | $131.00 K(+3.1%) | $931.00 K(-33.0%) |
| Sep 2019 | - | $127.00 K(-25.7%) | $1.39 M(-23.4%) |
| Jun 2019 | - | $171.00 K(-65.9%) | $1.81 M(-17.6%) |
| Mar 2019 | - | $502.00 K(-14.9%) | $2.20 M(-2.7%) |
| Dec 2018 | $2.26 M | $590.00 K(+7.1%) | $2.26 M(+0.4%) |
| Sep 2018 | - | $551.00 K(-1.3%) | $2.25 M(-1.5%) |
| Jun 2018 | - | $558.00 K(-0.9%) | $2.29 M(-4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $563.00 K(-3.3%) | $2.39 M(-5.4%) |
| Dec 2017 | $2.52 M(+10.9%) | $582.00 K(-0.5%) | $2.52 M(-4.0%) |
| Sep 2017 | - | $585.00 K(-11.1%) | $2.63 M(-2.8%) |
| Jun 2017 | - | $658.00 K(-5.9%) | $2.71 M(+5.8%) |
| Mar 2017 | - | $699.00 K(+1.7%) | $2.56 M(+12.3%) |
| Dec 2016 | $2.28 M(+43.1%) | $687.00 K(+3.9%) | $2.28 M(+13.6%) |
| Sep 2016 | - | $661.00 K(+29.9%) | $2.00 M(+16.4%) |
| Jun 2016 | - | $509.00 K(+21.5%) | $1.72 M(+6.5%) |
| Mar 2016 | - | $419.00 K(+1.2%) | $1.62 M(+1.6%) |
| Dec 2015 | $1.59 M(+6.8%) | $414.00 K(+9.2%) | $1.59 M(+1.4%) |
| Sep 2015 | - | $379.00 K(-6.2%) | $1.57 M(-1.2%) |
| Jun 2015 | - | $404.00 K(+2.5%) | $1.59 M(+3.8%) |
| Mar 2015 | - | $394.00 K(+0.5%) | $1.53 M(+2.7%) |
| Dec 2014 | $1.49 M(+9.6%) | $392.00 K(-1.5%) | $1.49 M(+1.9%) |
| Sep 2014 | - | $398.00 K(+15.0%) | $1.46 M(+2.2%) |
| Jun 2014 | - | $346.00 K(-2.3%) | $1.43 M(+0.4%) |
| Mar 2014 | - | $354.00 K(-2.7%) | $1.43 M(+4.8%) |
| Dec 2013 | $1.36 M(+33.7%) | $364.00 K(-0.8%) | $1.36 M(+6.9%) |
| Sep 2013 | - | $367.00 K(+7.9%) | $1.27 M(+9.2%) |
| Jun 2013 | - | $340.00 K(+17.6%) | $1.17 M(+7.8%) |
| Mar 2013 | - | $289.00 K(+4.7%) | $1.08 M(+6.3%) |
| Dec 2012 | $1.02 M(+11.6%) | $276.00 K(+6.2%) | $1.02 M(+37.2%) |
| Sep 2012 | - | $260.00 K(+1.6%) | $741.00 K(+54.1%) |
| Jun 2012 | - | $256.00 K(+13.8%) | $481.00 K(+113.8%) |
| Mar 2012 | - | $225.00 K | $225.00 K |
| Dec 2011 | $911.00 K(+84.4%) | - | - |
| Dec 2010 | $494.00 K | - | - |
FAQ
- What is Regulus Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Regulus Therapeutics?
- What is Regulus Therapeutics annual D&A year-on-year change?
- What is Regulus Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly D&A year-on-year change?
- What is Regulus Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Regulus Therapeutics?
- What is Regulus Therapeutics TTM D&A year-on-year change?
What is Regulus Therapeutics annual depreciation & amortization?
The current annual D&A of RGLS is $227.00 K
What is the all time high annual D&A for Regulus Therapeutics?
Regulus Therapeutics all-time high annual depreciation & amortization is $2.52 M
What is Regulus Therapeutics annual D&A year-on-year change?
Over the past year, RGLS annual depreciation & amortization has changed by +$105.00 K (+86.07%)
What is Regulus Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of RGLS is $90.00 K
What is the all time high quarterly D&A for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly depreciation & amortization is $699.00 K
What is Regulus Therapeutics quarterly D&A year-on-year change?
Over the past year, RGLS quarterly depreciation & amortization has changed by +$1000.00 (+1.12%)
What is Regulus Therapeutics TTM depreciation & amortization?
The current TTM D&A of RGLS is $336.00 K
What is the all time high TTM D&A for Regulus Therapeutics?
Regulus Therapeutics all-time high TTM depreciation & amortization is $2.71 M
What is Regulus Therapeutics TTM D&A year-on-year change?
Over the past year, RGLS TTM depreciation & amortization has changed by +$34.00 K (+11.26%)